A 16-year-old boy in a coma (Glasgow scale 3) with general seizures was admitted to the intensive care unit. No palpable pulse necessitated cardiac massage. A blood specimen submitted to this laboratory tested positive for tricyclic antidepressants (TCA) by EMIT (Behring, Cupertino, CA) and negative by FPIA (Abbott, Wiesbaden, Germany). A number of antidepressants were screened for in blood by a high-performance liquid chromatographic (HPLC) method (1): amineptine, amitriptyline, amoxapine, clomipramine, desipramine, dosulepine, doxepin, fluoxetine, imipramine, maprotiline, metapramine, mianserine, nomifensine, nortriptyline, opipramol, propizepine, protriptyline, quinupramine, tianeptine, trimipramine, and vilox,~ine. None of these compounds were found in this sample. Drug screening for phenothiazines (2), which are known to be a frequent cause of falsepositive results with immunoassays (3), was negative. A comprehensive drug test, performed by HPLC with diode-array detection (4), identified buflomedil, a peripheral vasodilator, at a concentration of 28 mg/L in this specimen. Studies were then performed with drug-free plasma samples spiked with buflomedil in a concentration range of 1 to 100 mg/L. A positive result for TCA was obtained for 13 mg/L with EMIT and 85 mg/L with FPIA. These results demonstrate that buflomedil cross-reacts with TCA in both systems at concentrations that can be found in acute intoxications. Indeed, whereas therapeutic plasma values of buflomedil are 1 to 4 rag/L, cardiotoxicity may occur as soon as plasma concentrations are greater than 10 mg/L (5).
